Avid Bioservices (CDMO) Reports Q3 Loss of $0.05/Share

Avid Bioservices (NASDAQ: CDMO) reported Q3 EPS of ($0.05), versus ($0.28) reported last year. Revenue for the quarter came in at $13.8 million, versus $6.8 million reported last year.

For earnings history and earnings-related data on Avid Bioservices (CDMO) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings
• Tutor Perini launches $400M senior notes offering due 2033